- The spherical observed participation from Anthill Ventures.
- The funding will enable Cureous Labs to manufacture its first batch of models, assemble inventory, and improve its workforce with key hires in product sales and enterprise enchancment. It’ll moreover fund the launch of the company’s first Disinfection Centre, facilitate product safety testing and certifications, and velocity up the expansion of its product portfolio for present B2B prospects.
- Cureous Labs has earned prestigious recognition by means of grants and awards from BIRAC, MeitY, the Bill & Melinda Gates Foundation, is a Swissnex AIT Awardee, and has been supported by Social Alpha and the SBI Foundation for its impactful healthcare enhancements.
- Thus far, Inflection Degree Ventures has invested over INR 800 Cr all through 220+ startups.
Bangalore,August 13, 2025 – Cureous Labs, an progressive medical know-how startup centered on enhancing affected particular person care and nursing effectivity, has raised ₹1.66 crore in a Seed funding spherical led by Inflection Degree Ventures (IPV), with participation from Anthill Ventures.
The funding can be utilized to manufacture the first batch of Cureous’ flagship automated affected particular person repositioning strategies (Eturnal™), assemble inventory, and scale enterprise operations by means of strategic hiring in product sales and enterprise enchancment. It’ll moreover assist the launch of the company’s first disinfection Centre, enable product safety testing and certifications, and improve the product portfolio for B2B prospects all through India.
Asish Mohandas, Founder & CEO of Cureous Labs, is a Biodesign Fellow from the distinguished Faculty of Worldwide Biodesign at AIIMS & IIT Delhi and holds a Grasp of Design from IIT Kanpur. He’s moreover the first Nationwide James Dyson Awardee for a medical system developed all through his time at IIT Kanpur. With a sturdy foundation in healthcare innovation and user-centered design, Asish brings deep expertise in creating impactful medical utilized sciences tailored to the Indian healthcare panorama.
Vinay Bansal, Founder, IPV says, “What drew us to place cash into Cureous Labs is their dedication to the ‘Prevention is more healthy than Treatment’ idea. Everywhere in the world there are a variety of bedridden victims affected by pressure accidents, together with to the already present sicknesses. Furthermore, it moreover locations strain on the caregivers making it tedious and harmful for them to handle the victims. Cureous Labs has used know-how to ease the burden of care whereas making pressure harm prevention further cheap and accessible to organizations all through the globe.”
Cureous Labs has developed India’s first retrofittable computerized affected particular person repositioning system with superior pressure discount, designed to help forestall bedsores and cut back caregiver accidents. Being priced at merely 1/fifth the worth of worldwide choices, the reply turns into every accessible along with cost-effective. The reply is constructed on better than 2 years of intensive scientific evaluation and notion from all through 100+ Hospitals in India and Australia.
Cureous Labs’ models are deployed all through hospitals, rehabilitation amenities, and residential care settings which showcases its real-world utilization. With over 30,000 hours of utilization and better than 14,000 automated affected particular person turns, this know-how has confirmed its credibility and affect. The startup is in the mean time working an full of life B2B and B2C product sales and rental pilots all through South India.
Asish Mohandas, the founder and CEO of Cureous Labs added: “At Cureous, our mission is to create utilized sciences that empower neutral residing. Eturnal™, our one-of-a-kind automated affected particular person turning decision, helps forestall pressure accidents whereas lowering caregiver dependency and vitality. We goal to assemble a portfolio of choices for geriatric and long-term care. IPV’s early notion in our imaginative and prescient gives us the boldness and sources to scale Cureous proper right into a category-defining agency on this home.”
The worldwide market for pressure harm prevention and affected particular person care is substantial, with over 1.1 billion people aged above 60 and 140 million over the age of 80, highlighting the rising need for aged care choices. An estimated 154 million people worldwide are bedridden and liable to creating pressure accidents, contributing to a worldwide market dimension of $277 billion. In India, the Full Addressable Market (TAM) stands at $8.34 billion, with a Serviceable Obtainable Market (SAM) of $1.56 billion and a Serviceable Obtainable Market (SOM) of $656 million, indicating sturdy potential for scalable affect and growth.
About Cureous Labs:
Cureous Labs is a MedTech spinoff from the distinguished Biodesign Fellowship at AIIMS & IIT Delhi, dedicated to creating intelligent, automated choices for pressure harm prevention. Its flagship product Eturnal™ offers a first-of-its-kind repositioning system that minimizes caregiver effort whereas enhancing affected particular person comfort and safety. Designed to seamlessly match into homes, hospitals, and senior care providers, Cureous is redefining necessities in long-term and vital care assist.
About Inflection Degree Ventures and Physis Capital:
Inflection Degree Ventures (IPV) is an angel investing platform with over 24,000+ CXOs, HNIs, and Professionals to collectively put cash into startups. The company helps new-age entrepreneurs by providing them with monetary & experiential capital and connecting them with a varied group of merchants. IPV has launched a $50 Mn CAT 2 VC fund, Physis Capital, to place cash into Pre-Sequence A to Sequence B growth-stage start-ups. The fund has already deployed capital in six startups thus far, with a few presents in superior ranges of pipeline.
Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our publication, and be part of our rising neighborhood at nextbusiness24.com
